Terms: = Prostate cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Diagnosis
24 results:
1. Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome.
Cerrato C; Pandolfo SD; Autorino R; Panunzio A; Tafuri A; Porcaro AB; Veccia A; De Marco V; Cerruto MA; Antonelli A; Derweesh IH; Maresma MCM
World J Urol; 2023 Jul; 41(7):1741-1749. PubMed ID: 36964236
[TBL] [Abstract] [Full Text] [Related]
2. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Bancroft EK; Page EC; Brook MN; Thomas S; Taylor N; Pope J; McHugh J; Jones AB; Karlsson Q; Merson S; Ong KR; Hoffman J; Huber C; Maehle L; Grindedal EM; Stormorken A; Evans DG; Rothwell J; Lalloo F; Brady AF; Bartlett M; Snape K; Hanson H; James P; McKinley J; Mascarenhas L; Syngal S; Ukaegbu C; Side L; Thomas T; Barwell J; Teixeira MR; Izatt L; Suri M; Macrae FA; Poplawski N; Chen-Shtoyerman R; Ahmed M; Musgrave H; Nicolai N; Greenhalgh L; Brewer C; Pachter N; Spigelman AD; Azzabi A; Helfand BT; Halliday D; Buys S; Ramon Y Cajal T; Donaldson A; Cooney KA; Harris M; McGrath J; Davidson R; Taylor A; Cooke P; Myhill K; Hogben M; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Dias A; Dudderidge T; Eccles DM; Green K; Eyfjord J; Falconer A; Foster CS; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Lilja H; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra AV; Moynihan C; Ni Raghallaigh H; Rennert G; Collier R; ; Offman J; Kote-Jarai Z; Eeles RA
Lancet Oncol; 2021 Nov; 22(11):1618-1631. PubMed ID: 34678156
[TBL] [Abstract] [Full Text] [Related]
3. Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.
Wei J; Yang W; Shi Z; Lu L; Wang Q; Resurreccion WK; Engelmann V; Zheng SL; Hulick PJ; Cooney KA; Isaacs WB; Helfand BT; Lu J; Xu J
Prostate; 2021 Sep; 81(13):1002-1008. PubMed ID: 34254341
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of Metachronous Quintuple cancer Involving the Stomach, Rectum, Colon, Liver and prostate].
Kihara Y; Takeda Y; Ohmura Y; Katsura Y; Sakamoto T; Shinke G; Taguchi I; Nagano T; Kawai K; Kitahara T; Hiraki M; Masuzawa T; Takeno A; Hata T; Murata K
Gan To Kagaku Ryoho; 2021 Apr; 48(4):608-611. PubMed ID: 33976064
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence and clinicopathological/molecular characteristics of mismatch repair protein-deficient tumours among surgically treated patients with prostate cancer in a Japanese hospital-based population.
Kagawa M; Kawakami S; Yamamoto A; Suzuki O; Eguchi H; Okazaki Y; Akagi K; Tamaru JI; Arai T; Yamaguchi T; Ishida H
Jpn J Clin Oncol; 2021 Apr; 51(4):639-645. PubMed ID: 33244609
[TBL] [Abstract] [Full Text] [Related]
6. DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell features.
Lotan TL; Kaur HB; Alharbi AM; Pritchard CC; Epstein JI
Histopathology; 2019 May; 74(6):836-843. PubMed ID: 30636012
[TBL] [Abstract] [Full Text] [Related]
7. Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous prostate cancer with Intact MMR: diagnosis and Analysis of the Family Pedigree.
Liu W; Zhang D; Tan SA; Liu X; Lai J
Anticancer Res; 2018 Aug; 38(8):4847-4852. PubMed ID: 30061258
[TBL] [Abstract] [Full Text] [Related]
8. Tumor development in Japanese patients with Lynch syndrome.
Saita C; Yamaguchi T; Horiguchi SI; Yamada R; Takao M; Iijima T; Wakaume R; Aruga T; Tabata T; Koizumi K
PLoS One; 2018; 13(4):e0195572. PubMed ID: 29672549
[TBL] [Abstract] [Full Text] [Related]
9. Sebaceous tumours: more than skin deep.
Jockenhöfer F; Schimming TT; Schaller J; Moege J; Livingstone E; Salva KA; Zimmer L; Schadendorf D; Rösch A
Gut; 2018 Nov; 67(11):1957. PubMed ID: 29247065
[TBL] [Abstract] [Full Text] [Related]
10. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract] [Full Text] [Related]
11. Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate.
Schweizer MT; Cheng HH; Tretiakova MS; Vakar-Lopez F; Klemfuss N; Konnick EQ; Mostaghel EA; Nelson PS; Yu EY; Montgomery B; True LD; Pritchard CC
Oncotarget; 2016 Dec; 7(50):82504-82510. PubMed ID: 27756888
[TBL] [Abstract] [Full Text] [Related]
12. A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer.
Kerr L; Rewhorn MJ; Longmuir M; Fraser S; Walsh S; Andrew N; Leung HY
BMC Cancer; 2016 Jul; 16():529. PubMed ID: 27456091
[TBL] [Abstract] [Full Text] [Related]
13. High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry.
Rosty C; Walsh MD; Lindor NM; Thibodeau SN; Mundt E; Gallinger S; Aronson M; Pollett A; Baron JA; Pearson S; Clendenning M; Walters RJ; Nagler BN; Crawford WJ; Young JP; Winship I; Win AK; Hopper JL; Jenkins MA; Buchanan DD
Fam Cancer; 2014 Dec; 13(4):573-82. PubMed ID: 25117503
[TBL] [Abstract] [Full Text] [Related]
14. prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study.
Asimakopoulos AD; Del Fabbro D; Miano R; Santonico M; Capuano R; Pennazza G; D'Amico A; Finazzi-Agrò E
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):206-11. PubMed ID: 24686772
[TBL] [Abstract] [Full Text] [Related]
15. Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28].
See WA
Urol Oncol; 2013 Jul; 31(5):716. PubMed ID: 23796201
[TBL] [Abstract] [Full Text] [Related]
16. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
Win AK; Lindor NM; Young JP; Macrae FA; Young GP; Williamson E; Parry S; Goldblatt J; Lipton L; Winship I; Leggett B; Tucker KM; Giles GG; Buchanan DD; Clendenning M; Rosty C; Arnold J; Levine AJ; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Hopper JL; Jenkins MA
J Natl Cancer Inst; 2012 Sep; 104(18):1363-72. PubMed ID: 22933731
[TBL] [Abstract] [Full Text] [Related]
17. cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic markers of early tumor development.
Dumitrescu RG
Methods Mol Biol; 2012; 863():3-14. PubMed ID: 22359284
[TBL] [Abstract] [Full Text] [Related]
19. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
Phé V; Cussenot O; Rouprêt M
BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
[TBL] [Abstract] [Full Text] [Related]
20. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract] [Full Text] [Related]
[Next]
